Is SNPS a Buy or a Sell? The Bull and Bear Case (2026)

Last updated July 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Synopsys (SNPS) rests on EDA duopoly and AI chip demand: Synopsys and Cadence dominate electronic design automation, and the explosion of AI accelerators, custom silicon, and advanced-node designs increases the value and complexity of the tools chipmakers need. The bear case rests on the clearest near-term risk is China: US export controls have required licenses for sales to Chinese entities, disrupted orders, and weighed on guidance, and further tightening is outside the company's control. Analysts covering it publish targets from $414.77 to $650.00 against a $380.26 price, so even the professionals disagree by 42% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Synopsys, Inc. is a leader in electronic design automation, the specialized software, intellectual property (IP), and services that semiconductor and systems companies use to design, verify, and manufacture chips. Along with Cadence and Siemens EDA, it sits inside a tight oligopoly; Synopsys and Cadence together are often cited at roughly 85 percent of the EDA market. Its tools are embedded deep in the design flow for advanced logic, memory, and AI accelerators, which makes revenue largely recurring and switching costs high. In July 2025 Synopsys closed its roughly $35 billion acquisition of Ansys, adding physics-based simulation and analysis and expanding the company from chip-level design toward full system design, a combined market management sizes near $31 billion. In fiscal 2026 the Ansys integration became the defining driver of results. Second-quarter FY2026 revenue was about $2.28 billion with a non-GAAP operating margin near 39.5 percent and non-GAAP EPS around $3.35, all ahead of guidance, and the company raised full-year revenue guidance to roughly $9.63 to $9.71 billion. Management is pushing an AI-centric roadmap, including Multiphysics Fusion that blends Ansys simulation engines into EDA and agentic AI design workflows it says can lift productivity meaningfully. At the same time, US export controls on China have forced licensing on sales to Chinese customers and weighed on that region, a headwind Synopsys has flagged directly in its guidance and outlook.

The bull case: what would have to be true for $650.00

The most optimistic published target on SNPS is $650.00, +70.9% from the $380.26 price as of July 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. EDA duopoly and AI chip demand

Synopsys and Cadence dominate electronic design automation, and the explosion of AI accelerators, custom silicon, and advanced-node designs increases the value and complexity of the tools chipmakers need. Because EDA software and IP are mission-critical and deeply embedded in design flows, revenue is largely recurring with high switching costs. As long as leading-edge chip design keeps growing, Synopsys sits in a structurally advantaged position at the center of it.

2. Ansys integration and system-level expansion

The roughly $35 billion Ansys acquisition, closed in July 2025, extends Synopsys from chip design into physics-based simulation for entire systems, widening its addressable market toward a combined figure management sizes near $31 billion. Early cross-selling, more than 30 cited full-flow technical wins, and Multiphysics Fusion capabilities are the proof points. The company also targets realizing about half of committed cost synergies by the end of fiscal 2026.

3. AI-driven design tools

Synopsys is building agentic AI workflows and multiphysics capabilities it says can deliver large productivity gains, with early trials cited at up to threefold faster design closure for some analog workloads. If AI features become table stakes for advanced design and Synopsys leads there, it can defend pricing and share while giving customers a reason to consolidate onto its platform rather than splitting spend across vendors.

4. Recurring model and margin expansion

Much of Synopsys revenue is time-based and recurring, which smooths results across semiconductor cycles relative to hardware makers. Raised FY2026 guidance pointed toward a non-GAAP operating margin near 41 percent, and management frames Ansys synergies plus scale as a path to further margin gains over time. Consistent execution on synergies and margins is central to justifying the stock's premium valuation.

The bear case: what would have to be true for $414.77

The most pessimistic published target is $414.77, +9.1% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Synopsys is worth if the risks below bite instead of the drivers above.

The clearest near-term risk is China: US export controls have required licenses for sales to Chinese entities, disrupted orders, and weighed on guidance, and further tightening is outside the company's control. Integrating a roughly $35 billion Ansys acquisition is a major undertaking, with execution, cost-synergy, and culture risk while Synopsys simultaneously defends core EDA share against a resurgent Cadence, which is expanding through its own Hexagon design-business deal. The stock also carries a premium, high-multiple valuation, so any growth disappointment, margin slip, or slower semiconductor spending can compress the multiple sharply, as a large 2026 drawdown showed. Design IP margins and broader chip-cycle softness add further variability to results.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding SNPS already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on SNPS

25 analysts cover SNPS, with an average target of $564.43 (+48.4% against $380.26) and a split of 18 buy, 5 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the SNPS forecast and price target page.

How is SNPS valued? (as of Jul 2026)

Price
$380.26
Market cap
$72.81B
P/E (TTM)
86.82
Forward P/E
22.01
Price / book
2.39
Beta
1.22
52-week range
$366.00 to $651.73

Snapshot for SNPS as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Q2 FY2026 revenue: ~$2.28 billion, ahead of company guidance
  • Q2 FY2026 non-GAAP EPS: ~$3.35, above the guided range
  • Non-GAAP operating margin: ~39.5% in Q2, with full-year guidance raised toward ~41%
  • FY2026 revenue guidance: ~$9.63 to $9.71 billion (midpoint ~$9.665 billion), raised after Q2
  • FY2026 non-GAAP EPS guidance: ~$14.76 at midpoint, increased after Q2
  • Valuation posture: Trades at a premium, high-multiple valuation typical of leading design-software names

Figures are approximate, reflect non-GAAP measures the company emphasizes, and are tied to the asOf date; verify live numbers before acting. Note that Ansys is now consolidated, so year-over-year comparisons are inflated by the acquisition rather than reflecting pure organic growth, and some guidance items include accounting shifts (such as recognizing certain Ansys channel revenue on a gross basis) that are neutral to EPS. A premium multiple leaves little room for disappointment, so integration progress and the China trajectory matter as much as headline beats.

How do you decide if SNPS is a buy?

Rather than asking whether SNPS is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold SNPS indirectly through an index or sector ETF before adding more.

What would change your mind on SNPS

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: EDA duopoly and AI chip demand stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: the clearest near-term risk is China: US export controls have required licenses for sales to Chinese entities, disrupted orders, and weighed on guidance, and further tightening is outside the company's control fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the SNPS stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about SNPS against your real portfolio and see your actual exposure before deciding.

Investing in Synopsys with AI

Connect the broker you already use and ask Walnut's AI how SNPS fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is SNPS a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on EDA duopoly and AI chip demand, with q2 fy2026 revenue at ~$2.28 billion, ahead of company guidance. The bear case rests on the clearest near-term risk is China: US export controls have required licenses for sales to Chinese entities, disrupted orders, and weighed on guidance, and further tightening is outside the company's control. Analysts covering it are spread from $414.77 to $650.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell SNPS?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The clearest near-term risk is China: US export controls have required licenses for sales to Chinese entities, disrupted orders, and weighed on guidance, and further tightening is outside the company's control. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $414.77, +9.1% from the $380.26 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for SNPS?

+

EDA duopoly and AI chip demand. Synopsys and Cadence dominate electronic design automation, and the explosion of AI accelerators, custom silicon, and advanced-node designs increases the value and complexity of the tools chipmakers need. The most optimistic analyst target on SNPS is $650.00, +70.9% from the $380.26 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for SNPS?

+

The clearest near-term risk is China: US export controls have required licenses for sales to Chinese entities, disrupted orders, and weighed on guidance, and further tightening is outside the company's control. Integrating a roughly $35 billion Ansys acquisition is a major undertaking, with execution, cost-synergy, and culture risk while Synopsys simultaneously defends core EDA share against a resurgent Cadence, which is expanding through its own Hexagon design-business deal. The stock also carries a premium, high-multiple valuation, so any growth disappointment, margin slip, or slower semiconductor spending can compress the multiple sharply, as a large 2026 drawdown showed. Design IP margins and broader chip-cycle softness add further variability to results. The most pessimistic published target is $414.77, +9.1% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Synopsys do?

+

Synopsys, Inc.

What would have to change for SNPS to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (EDA duopoly and AI chip demand) stalling in the reported numbers rather than in the narrative, the risk above (the clearest near-term risk is China: US export controls have required licenses for sales to Chinese entities, disrupted orders, and weighed on guidance, and further tightening is outside the company's control) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Is SNPS a good stock to buy right now?

+

That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is a dominant EDA position, recurring revenue, AI chip demand, and the Ansys deal expanding Synopsys into system-level simulation with rising margins. The bear case is China export headwinds that have pressured guidance, heavy integration and competitive execution risk against Cadence, and a premium valuation that leaves little room for disappointment. Weigh both against your portfolio.

What does Synopsys actually do?

+

Synopsys makes electronic design automation software, the specialized tools chip companies use to design and verify semiconductors, along with licensable chip IP and services. After acquiring Ansys, it also provides physics-based simulation for whole systems. Its products sit deep in the semiconductor design flow, so most advanced chips and AI accelerators are created using Synopsys or a close competitor's tools, generating largely recurring revenue.

What was the Ansys acquisition about?

+

Synopsys closed its roughly $35 billion acquisition of Ansys in July 2025. Ansys is a leader in engineering simulation and multiphysics analysis, so the deal extends Synopsys from chip-level design into simulating entire systems. Management frames the combination as widening its addressable market toward a figure near $31 billion and enabling capabilities like Multiphysics Fusion, though integrating a target that large carries real execution and synergy risk.

Walnut is informational, not investment advice, and gives no verdict on SNPS. Analyst targets referenced here come from a July 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

Related stocks

    Is SNPS a Buy or a Sell? The Bull and Bear Case (2026), Walnut